Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FDJ78
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,362
Award facts
- Contract value 100% obligated
- $18,362.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $18,362.00 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Botox 200 Unit Vials. This delivery order, with an ultimate completion date of June 23, 2025, represents a specific procurement under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The contract carries no set-aside designation, allowing the company to compete on its merits as a small business contractor. Performance will be executed at the company's primary location in Park Ridge, IL.
This award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing specialized pharmaceutical products to support Department of Defense healthcare facilities. The company's portfolio with the DLA encompasses an extensive range of medical products, including prescription medications, biologics, and medical consumables distributed to military health facilities nationwide. The Botox delivery order exemplifies the company's capability to supply specialty pharmaceutical products essential to federal healthcare operations, maintaining the agency's inventory of high-value pharmaceutical items.
Quick answers
Who was awarded contract SPE2DB25FDJ78?
SPE2DB25FDJ78 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FDJ78 worth?
The government has obligated $18,362 on SPE2DB25FDJ78.
Is contract SPE2DB25FDJ78 an order under another contract?
Yes. SPE2DB25FDJ78 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDJ78 competed?
The extent of competition for SPE2DB25FDJ78 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award